SEVERE ALOPECIA AREATA

Clinical trials for SEVERE ALOPECIA AREATA explained in plain language.

Never miss a new study

Get alerted when new SEVERE ALOPECIA AREATA trials appear

Sign up with your email to follow new studies for SEVERE ALOPECIA AREATA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New pill could regrow hair in severe alopecia – trial begins

Disease control Not yet recruiting

This study tests a drug called deuruxolitinib in Japanese adults aged 18-65 with severe alopecia areata, an autoimmune condition causing significant scalp hair loss. Participants must have at least 50% hair loss. The trial measures how well the drug regrows hair and how satisfied…

Matched conditions: SEVERE ALOPECIA AREATA

Phase: PHASE3 • Sponsor: Sun Pharma Japan Limited • Aim: Disease control

Last updated Jun 27, 2026 13:03 UTC

SEVERE ALOPECIA AREATA

Get alerted when new SEVERE ALOPECIA AREATA trials appear

New pill could regrow hair in severe alopecia – trial begins